Trump administration reframes subsidy termination as healthcare reform strategy
Trump administration justifies subsidy end as healthcare reform, not beneficiary policy.
Event / Politics
Medicare Part D Subsidy Termination
Trump administration terminates Biden-era Medicare Part D Premium Stabilization Demonstration subsidies at end of 2026, expected to increase premiums for approximately half of 24.9 million beneficiaries by up to $20 monthly starting 2027.
2 reported locations
Daily activity
0 articles0 articles
2026-08-14 to 2026-11-11 · UTC publication dates
Coverage begins 30 Jul, 00:19 UTC
Follow the documented timeline or explore the related reporting.
What happened
Trump administration ends Medicare Part D premium subsidy program after 2026
The Centers for Medicare & Medicaid Services announced that the Part D Premium Stabilization Demonstration subsidy program will expire at the end of 2026, one year earlier than originally scheduled. The program was created by the Biden administration in 2024 to stabilize premiums under changes from the Inflation Reduction Act. CMS said insurers have gained sufficient experience to price plans without additional taxpayer support.
CMS Administrator Mehmet Oz criticizes Biden subsidy as insurance company bailout
CMS Administrator Dr. Mehmet Oz characterized the Biden administration's subsidy program as a bailout, stating that it 'gave BILLIONS of taxpayer money DIRECTLY to Big Insurance Companies,' which he described as 'unacceptable.' Oz framed the subsidy termination as 'stabilizing the market' so the bailout is no longer needed.
Medicare Part D premiums projected to increase 6 percent in 2027
CMS released preliminary 2027 Medicare Part D bid information showing the national base beneficiary premium will rise from $38.99 in 2026 to $41.33 in 2027, an increase of approximately 6 percent. Most beneficiaries are expected to face premium increases of less than $10, though some may see increases as high as $20 per month, while others may see premiums fall.
Nearly 25 million people enrolled in standalone Medicare Part D drug plans in 2026
As of 2026, 24.9 million people were enrolled in standalone Medicare Part D prescription drug plans, up from 23.2 million in 2025. These plans are used by tens of millions of older and disabled beneficiaries for prescription drug coverage.
Trump administration pursues broader Medicare and healthcare spending reforms
The Trump administration is pursuing multiple changes to government health programs, including a proposal to overhaul Medicare physician payments and increase federal healthcare spending oversight. These broader reforms align with the President's stated goal of ending taxpayer-funded subsidies to insurance companies and health care intermediaries.
Biden administration subsidy reduced Medicare Part D premiums by 27-40 percent
The temporary subsidy program lowered average standalone Part D premiums significantly: in 2025, it reduced average monthly premiums from $65 to $39 (40 percent reduction after accounting for statutory premium caps), and in 2026, it lowered projected premiums from $60 to $44 (approximately 27 percent reduction). The subsidy cost taxpayers $6.2 billion in 2025 and $3.6 billion in 2026.
Read the coverage
2 alternative perspectives
Medicare Part D premium subsidies set to expire after 2026
Medicare Part D subsidies expire after 2026, projected to increase premiums 6% for 25 million beneficiaries.